Celldex (CLDX) Tops Q2 EPS by 12c
Get Alerts CLDX Hot Sheet
Join SI Premium – FREE
Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.94), $0.12 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $22 thousand versus the consensus estimate of $802.64 thousand.
For earnings history and earnings-related data on Celldex (CLDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,730 at Nomura/Instinet
- Coforge Ltd (COFORGE:IN) PT Raised to INR2,460 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share